Michno W

Chemical signatures delineate heterogeneous amyloid plaque populations across the Alzheimer's disease spectrum.

Koutarapu S, Ge J, Dulewicz M, ..., Schöll M, Hanrieder J

bioRxiv - (-) - [2024-06-03; online 2024-06-03]

Integrated Microscopy Technologies Gothenburg [Service]

Correlative Chemical Imaging Identifies Amyloid Peptide Signatures of Neuritic Plaques and Dystrophy in Human Sporadic Alzheimer's Disease.

Koutarapu S, Ge J, Jha D, ..., Michno W, Hanrieder J

Brain Connect 13 (5) 297-306 [2023-06-00; online 2022-10-07]

Integrated Microscopy Technologies Gothenburg [Service]

Chemical traits of cerebral amyloid angiopathy in familial British-, Danish-, and non-Alzheimer's dementias.

Michno W, Koutarapu S, Camacho R, ..., Lashley T, Hanrieder J

J. Neurochem. 163 (3) 233-246 [2022-11-00; online 2022-09-25]

Integrated Microscopy Technologies Gothenburg [Collaborative]

Structural amyloid plaque polymorphism is associated with distinct lipid accumulations revealed by trapped ion mobility mass spectrometry imaging.

Michno W, Wehrli PM, Koutarapu S, ..., Hopf C, Hanrieder J

J. Neurochem. 160 (4) 482-498 [2022-02-00; online 2021-12-26]

Integrated Microscopy Technologies Gothenburg [Collaborative]

Following spatial Aβ aggregation dynamics in evolving Alzheimer's disease pathology by imaging stable isotope labeling kinetics.

Michno W, Stringer KM, Enzlein T, ..., Edwards FA, Hanrieder J

Sci Adv 7 (25) - [2021-06-00; online 2021-06-16]

Integrated Microscopy Technologies Gothenburg [Collaborative]

Chemical imaging of evolving amyloid plaque pathology and associated Aβ peptide aggregation in a transgenic mouse model of Alzheimer's disease.

Michno W, Wehrli P, Meier SR, ..., Blennow K, Hanrieder J

J. Neurochem. 152 (5) 602-616 [2020-03-00; online 2019-11-06]

Integrated Microscopy Technologies Gothenburg [Collaborative]